Endotoxin testing explained

Endotoxin is the single most important quality variable in injectable peptides that almost nobody talks about. Most "this peptide gave me terrible side effects" reports turn out, when investigated, to be endotoxin reactions — not anything intrinsic to the peptide. Endotoxin testing is the test that separates injectable-grade material from material that should never be put in a body, and the LAL assay number on a COA is the most consequential number on the page for many users.

What endotoxin actually is

Endotoxin is the technical name for lipopolysaccharide (LPS), a molecule that lives in the outer membrane of Gram-negative bacteria. When those bacteria die — during fermentation, manufacturing, or storage — they release endotoxin into whatever they were in. Heat-sterilization kills the bacteria but does not destroy the endotoxin: the molecule is heat-stable, survives autoclaving, and persists in the product.

When endotoxin enters the bloodstream via injection, the immune system recognizes it as a bacterial signal and mounts a response. Even small amounts trigger:

• Flu-like symptoms (fever, chills, body aches)
• Headaches
• Fatigue and malaise
• Local injection-site inflammation
• At high doses: severe systemic response (chills, vomiting, dangerous hemodynamic effects)

The dose-response curve is steep. A vial with double the acceptable endotoxin level can produce a meaningfully worse experience than a vial at threshold.

The LAL assay

LAL stands for Limulus Amebocyte Lysate. The assay uses a reagent derived historically from horseshoe crab blood (a recombinant version, rFC, is now also widely accepted) that clots in the presence of endotoxin. Three method variants:

Result is reported in EU/mg — endotoxin units per milligram of peptide. A peptide tested at 0.8 EU/mg has 0.8 endotoxin units per milligram of product.

Reading the EU/mg number

The thresholds that matter:

Pharmaceutical injectables target below 0.5 EU/mg, which is the FDA-aligned threshold for products dosed by injection. Research-chem peptides commonly aim for below 5 EU/mg, which is roughly an order of magnitude looser but still well within a range that most users tolerate without obvious endotoxin reactions.

A number well below either threshold is good; a number at or near threshold is acceptable; a number above threshold should be a hard pass for injectable use.

Why endotoxin causes most "peptide side effects"

The pattern that comes up repeatedly:

1. A user starts a peptide and feels fine for a few cycles
2. They reorder, sometimes from the same vendor, sometimes a new one
3. New batch produces flu-like reactions, fatigue, headaches
4. The user attributes the reaction to the peptide
5. The next batch from a different vendor is fine

What's almost always happening: the second batch had endotoxin at or above threshold, and the immune response is the bacterial-signal response, not anything specific to the peptide.

Indications that a side effect is endotoxin rather than peptide:

• Reaction is more "general illness" than "specific peptide effect"
• Onset is hours after injection, peaking at 4 to 12 hours
• Disappears within 24 to 48 hours of stopping
• Reproducible with the same batch, gone with a different batch
• Often worse with first injection of a new vial than later ones (unequal distribution)

What to ask of a vendor

A reasonable vendor will share endotoxin data. Specifics:

• The COA should list endotoxin in EU/mg
• The method should be specified (LAL gel-clot, kinetic chromogenic, kinetic turbidimetric, or rFC)
• The limit applied should be stated
• The result should be a specific number, not a "below threshold" pass/fail without value

Vendors that don't test endotoxin or won't share results are a hard pass for injectable use. The cost of a contaminated vial is several days of feeling sick at minimum and, in rare cases, something significantly worse.

What if endotoxin testing isn't on the COA?

Some research-chem COAs include only identity and purity. For an injectable peptide, that's incomplete. Options:

1. Ask the vendor for endotoxin data; reputable vendors will have it
2. Switch vendors to one that tests endotoxin routinely
3. For a vial in hand, send it for independent testing (some labs do single-vial endotoxin testing for around 100 to 200 USD)

The third option is overkill for normal sourcing but useful when investigating a side effect reaction.

Endotoxin and bacteriostatic water

Bacteriostatic water for injection (BAC) is itself tested for endotoxin and is generally clean. The endotoxin question is about the peptide vial, not the diluent. Reconstitution does not introduce endotoxin if both inputs are clean and the technique is reasonable.

For the technique side, see the reconstitution pillar.

Pharmaceutical vs research-chem standards

The 10x gap between pharmaceutical (0.5 EU/mg) and research-chem (5 EU/mg) thresholds reflects the difference in regulatory oversight, not in user tolerance. Most users tolerate research-chem-threshold endotoxin without obvious symptoms; some are more sensitive and notice even at low levels. There's individual variation.

For users who appear unusually endotoxin-sensitive, the pharmaceutical threshold (below 0.5 EU/mg) is a reasonable target. Some vendors test to that level; others test only to the research-chem threshold.

The bottom line

Endotoxin is the quality variable most likely to make a peptide cycle feel terrible. The COA should list endotoxin in EU/mg with the method specified. Below 0.5 is pharmaceutical, below 5 is research-chem-acceptable, above 5 is a pass. If a vendor doesn't test endotoxin, find one that does.

Related reading

• How to read a Certificate of Analysis
• Peptide purity explained
• Choosing a peptide vendor
• Counterfeit peptide red flags